A novel aptamer-based DNA diamond nanostructure for in vivo targeted delivery of epirubicin to cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel aptamer-based DNA diamond nanostructure for in vivo targeted delivery of epirubicin to cancer cells

Published:2017 Issue:25 Volume:7 Page:15181-15188
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Abnous Khalil¹²³⁴,Danesh Noor Mohammad⁵²³⁴⁶,Ramezani Mohammad⁵²³⁴,Lavaee Parirokh⁷⁸³⁴,Jalalian Seyed Hamid⁵²³⁴⁷,Yazdian-Robati Rezvan⁹¹⁰²³⁴,Emrani Ahmad Sarreshtehdar¹¹¹²²³⁴,Hassanabad Koroush Yousefi¹³¹⁴¹⁵¹⁶⁴,Taghdisi Seyed Mohammad¹⁷²³⁴^ORCID

Affiliation:

1. Pharmaceutical Research Center

2. Mashhad University of Medical Sciences

3. Mashhad

4. Iran

5. Nanotechnology Research Center

6. Research Institute of Sciences and New Technology

7. Academic Center For Education

8. Culture and Research (ACECR)-Mashhad Branch

9. Department of Pharmaceutical Biotechnology

10. School of Pharmacy

11. Cardiovascular Research Center

12. Ghaem Hospital

13. Department of Infectious Disease

14. Children Medical Center

15. North Khorasan University of Medical Sciences

16. Bojnord

17. Targeted Drug Delivery Research Center

Abstract

The clinical administration of epirubicin (Epi) in the treatment of cancer has been restricted, owing to its cardiotoxicity.

Funder

Mashhad University of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/RA/C6RA28234B

Reference30 articles.

1. Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel

2. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance

3. A Potential Daidzein Derivative Enhances Cytotoxicity of Epirubicin on Human Colon Adenocarcinoma Caco-2 Cells

4. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo

5. Self-Assembled Hybrids of Fluorescent Carbon Dots and PAMAM Dendrimers for Epirubicin Delivery and Intracellular Imaging

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers as an approach to targeted cancer therapy;Cancer Cell International;2024-03-16

2. Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures;International Journal of Pharmaceutics;2023-11

3. Doxorubicin-loaded micelles in tumor cell-specific chemotherapy;Environmental Research;2023-06

4. Targeted delivery of epirubicin to breast cancer cells using poly-aptamer DNA nanocarriers prepared by the RCA method with multiple repeats of aptamers of FOXM1 and AS1411;Drug Development and Industrial Pharmacy;2023-03-04

5. Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers;Frontiers in Cell and Developmental Biology;2022-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3